Asia PR News

RESEARCH TRIANGLE PARK, N.C., Sept. 30 /PRNewswire-AsiaNet/ –

Quintiles Transnational Corp. today announced the completion of the
previously announced agreement with Aptuit, Inc., to enter a strategic
partnership.

Aptuit has acquired three Quintiles business units - Preclinical Services,
Pharmaceutical Sciences and Clinical Trial Supplies - for approximately $125
million. The companies have signed a two-year commercial agreement
establishing arrangements to make these early development services available
through this agreement. The transaction also will enhance Quintiles’ cash
position while allowing greater focus on core clinical services and clinical
support services.

The three Quintiles business units employ about 1,400 people, primarily in
Kansas City, Mo.; Mt. Laurel, N.J.; Edinburgh, Scotland; and Singapore. Aptuit
plans to reorganize the units into three global business lines: Preclinical
Technologies, Pharmaceutical Sciences and Packaging & Logistics.

Quintiles helps improve healthcare worldwide by providing a broad range of
professional services, information and partnering solutions to the
pharmaceutical, biotechnology and healthcare industries. Headquartered near
Research Triangle Park, North Carolina, Quintiles has 16,000 employees, offices
in 50 countries and is the world’s leading pharmaceutical services
organization. For more information visit the company’s Web site at
http://www.quintiles.com

Information in this press release contains "forward-looking statements."
These statements involve risks and uncertainties that could cause actual
results to differ materially, including, without limitation, the ability of the
parties to operate under the alliance. Additional factors that could cause
actual results to differ materially are discussed in Quintiles’ recent filings
with the Securities and Exchange Commission, including but not limited to its
annual report on Form 10-K, its quarterly report on Form 10-Q and its current
reports on Form 8-K.

SOURCE: Quintiles Transnational Corp.

CONTACT: Dick Jones,
Media Relations,
+1-919-998-2091, or
media.info@quintiles.com, or

Greg Connors,
Investor Relations,
+1-919-998-2000, or
invest@quintiles.com,

both of Quintiles Transnational Corp.

Web site: http://www.quintiles.com